Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct

Updated on: December 19,2023

Ultrasound-guided surgery could be quicker, less painful and more effective for treating early form of breast cancer

by European Organisation for Research and Treatment of CancerAntonio Esgueva using IOUS to guide breast surgery. Credit: Antonio Esguega / EORTCUsing ultrasound to guide surgery for patients with duct

Updated on:December 19,2023

First immunotherapy success for triple-negative breast cancer

byQueen Mary, University of LondonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by

Updated on: December 18,2023

First immunotherapy success for triple-negative breast cancer

byQueen Mary, University of LondonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by

Updated on:December 18,2023

Patient's own immune cells effective as living medicine for melanoma

byNetherlands Cancer InstitutePreparing tumor-infiltrating lymphocyte therapy for melanoma patients in the lab. Credit: NKIA patient's own immune cells, multiplied into an army of billions o

Updated on: December 19,2023

Patient's own immune cells effective as living medicine for melanoma

byNetherlands Cancer InstitutePreparing tumor-infiltrating lymphocyte therapy for melanoma patients in the lab. Credit: NKIA patient's own immune cells, multiplied into an army of billions o

Updated on:December 19,2023

Capturing immunotherapy response in a blood drop

byJohns Hopkins University School of MedicineAn impressionist painting of a liquid biopsy. Credit: Valsamo Anagnostou x DALL-E, openAILiquid biopsies are blood tests that can serially measure ci

Updated on: October 14,2023

Capturing immunotherapy response in a blood drop

byJohns Hopkins University School of MedicineAn impressionist painting of a liquid biopsy. Credit: Valsamo Anagnostou x DALL-E, openAILiquid biopsies are blood tests that can serially measure ci

Updated on:October 14,2023

Automated detection of eye surface cancer

by ARC Centre of Excellence for Nanoscale BioPhotonicsA new automated non-invasive technique for diagnosing eye disease. Credit: ARC Centre of Excellence for Nanoscale BioPhotonicsResearchers hav

Updated on: May 25,2024

Automated detection of eye surface cancer

by ARC Centre of Excellence for Nanoscale BioPhotonicsA new automated non-invasive technique for diagnosing eye disease. Credit: ARC Centre of Excellence for Nanoscale BioPhotonicsResearchers hav

Updated on:May 25,2024

Researchers identify new therapeutic target for colorectal cancer

byRockefeller University PressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers at the University of Toronto have identified a key protein that support

Updated on: December 20,2023

Researchers identify new therapeutic target for colorectal cancer

byRockefeller University PressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers at the University of Toronto have identified a key protein that support

Updated on:December 20,2023

AI's Breakthroughs in Ovarian Cancer Diagnosis and Treatment

Updated on: June 12,2024

AI's Breakthroughs in Ovarian Cancer Diagnosis and Treatment

Updated on:June 12,2024

Advanced imaging may help in clinical treatment of prostate cancer

byEuropean Association of UrologyCredit: Pixabay/CC0 Public DomainAn advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a cleare

Updated on: January 10,2024

Advanced imaging may help in clinical treatment of prostate cancer

byEuropean Association of UrologyCredit: Pixabay/CC0 Public DomainAn advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a cleare

Updated on:January 10,2024

The chromatographic constitution of andiroba oil and its healing effects

by Impact JournalsHistopathological evaluation of oral mucositis on days 4, 8, 12 and 15. Credit: 2023 Gomes et al.A new research paper titled "The chromatographic constitution of andiroba oil an

Updated on: December 18,2023

The chromatographic constitution of andiroba oil and its healing effects

by Impact JournalsHistopathological evaluation of oral mucositis on days 4, 8, 12 and 15. Credit: 2023 Gomes et al.A new research paper titled "The chromatographic constitution of andiroba oil an

Updated on:December 18,2023

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

byLilly Matson| Analysis3 November 2021Share this articleAlmost all cervical cancers are caused by the human papilloma virus (HPV), depicted above.After decades of research,the UK im

Updated on: December 19,2023

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

byLilly Matson| Analysis3 November 2021Share this articleAlmost all cervical cancers are caused by the human papilloma virus (HPV), depicted above.After decades of research,the UK im

Updated on:December 19,2023

Pembrolizumab Active in Advanced Nasopharyngeal Carcinoma

August 29, 2017Jason HarrisPembrolizumab (Keytruda) induced an overall response rate of 25.9% and was well tolerated in patients with PD-L1–positive recurrent or metastatic nasopharyngeal carcinoma.Na

Updated on: October 24,2023

Pembrolizumab Active in Advanced Nasopharyngeal Carcinoma

August 29, 2017Jason HarrisPembrolizumab (Keytruda) induced an overall response rate of 25.9% and was well tolerated in patients with PD-L1–positive recurrent or metastatic nasopharyngeal carcinoma.Na

Updated on:October 24,2023

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Updated on: October 12,2023

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Updated on:October 12,2023